Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramiro Ribeiro

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Immunotherapy|January 17, 2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studiesJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Ophthalmology|December 28, 2020
Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular DegenerationLuísa S M Mendonça, Rhianon Perrott-Reynolds, Roy Schwartz, et al.
Experimental Eye Research|May 7, 2022
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trialsAntonio Yaghy, Aaron Y Lee, Pearse A Keane, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Immunotherapy|January 17, 2025
Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studiesJeffrey S Heier, Eleonora M Lad, Frank G Holz, et al.
Ophthalmology|December 28, 2020
Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular DegenerationLuísa S M Mendonça, Rhianon Perrott-Reynolds, Roy Schwartz, et al.
Experimental Eye Research|May 7, 2022
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trialsAntonio Yaghy, Aaron Y Lee, Pearse A Keane, et al.
Pageof 3